Medical Research Future Fund
On 25 September 2020, the Australian Government announced the investment of $25 million into research to improve the safe use of medicines and pharmacist-led interventions through the Medical Research Future Fund (MRFF).
Federal Minister for Health, Greg Hunt, announced the new Quality, Safety and Effectiveness of Medicine Use Intervention by Pharmacists MRFF Grant Opportunity, designed to support Medicines Safety as Australia’s 10th National Health Priority.
2022 Grant Opportunity – Quality, Safety and Effectiveness of Medicines Use and Medicine Intervention by Pharmacists
This grant opportunity will open on Thursday, 16 June 2022 and closes on Wednesday, 7 September 2022.
The 2022 Quality, Safety and Effectiveness of Medicine Use and Medicine Intervention by Pharmacists grant opportunity is part of the MRFF and the Preventive and Public Health Research Initiative. It provides researchers with funding to improve the safe and effective use of medicines.
In 2022, grants of up to $1.5 million will be available under four Streams to support eligible organisations to undertake research to support innovative approaches to improve the quality and cost‑effectiveness of preventive healthcare interventions.
The objective of the program is to provide grants to Australian medical research and medical innovation projects that align with the following streams:
- Stream 1: assess the feasibility (including cost effectiveness, and acceptability by patients and prescribing health professionals) of pharmacogenomic interventions by community pharmacists designed to optimise medication prescription and use.
- Stream 2: assess the feasibility (including cost effectiveness, scalability, and acceptability by patients and prescribing health professionals) of pharmacogenomic interventions to optimise the prescription and use of medicines for treating patients with cancer (oncology and supportive care).
- Stream 3: implement, validate, and cost approaches that involve community and hospital pharmacists collaborating to improve medication management at transition into the community.
- Stream 4: implement, validate, and cost approaches for pharmacist interventions in residential aged care using objective patient focused indicators.
The outcomes of the research funded by this grant is to improve the health and wellbeing of Australians by supporting the safe and effective use of prescription medicines, quality of care provided to patients, reducing hospital readmissions due to medication complications and evidence to support the safe and effective use of medicines in residential aged care.
More information is available here. Key documents, including the Grant opportunity guidelines, are available here.
Contact us using the form below to find out how PSA can support you with your 2022 grant application.